Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025)
NEW YORK — December 12, 2025 — Applied Therapeutics, Inc. (NASDAQ: APLT) is in the spotlight after announcing a definitive agreement to be acquired by Cycle Group Holdings Limited (“Cycle”), a rare-disease-focused company that operates as Cycle Pharmaceuticals. The headline